13F HOLDINGS REPORT
Caligan Partners LP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001420506-25-001290
Total Value
$479.2M
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LIQUIDIA CORPORATION | LQDA | 8,118,592 | $119.7M | 24.99% |
| 2 | VERONA PHARMA PLC | 925050106 | 1,436,878 | $91.2M | 19.04% |
| 3 | EXELIXIS INC | EXEL | 1,525,730 | $56.3M | 11.75% |
| 4 | MINERALYS THERAPEUTICS INC | MLYS | 2,149,667 | $34.1M | 7.12% |
| 5 | EVOLUS INC | EOLS | 2,731,154 | $32.9M | 6.86% |
| 6 | SAGE THERAPEUTICS INC | 78667J108 | 3,052,538 | $24.3M | 5.06% |
| 7 | BIOCRYST PHARMACEUTICALS INC | BCRX | 3,107,669 | $23.3M | 4.86% |
| 8 | ANIKA THERAPEUTICS INC | ANIK | 1,435,130 | $21.6M | 4.50% |
| 9 | AGIOS PHARMACEUTICALS INC | AGIO | 701,280 | $20.5M | 4.29% |
| 10 | REVOLUTION MEDICINES INC | RVMDW | 465,000 | $16.4M | 3.43% |
| 11 | MERUS N V | N5749R100 | 376,954 | $15.9M | 3.31% |
| 12 | Y-MABS THERAPEUTICS INC | 984241109 | 2,342,609 | $10.4M | 2.17% |
| 13 | ABIVAX SA | AAVXF | 1,269,119 | $7.9M | 1.66% |
| 14 | VERRICA PHARMACEUTICALS INC | VRCA | 8,992,954 | $4.0M | 0.83% |
| 15 | REZOLUTE INC | RZLT | 141,309 | $409,796 | 0.09% |
| 16 | TYRA BIOSCIENCES INC | TYRA | 25,000 | $232,500 | 0.05% |